专利号:WO-2016187028-A1 优先权日:2015-05-15 标 题 :Heteroaryl compounds, synthesis thereof, and intermediates thereto 发明人:FERNANDEZ PAUL FRANK; FERRETTI ANTONIO CHRISTIAN; HAN JIANXIN; TRAVERSE JOHN; TUNG HSIEN-HSIN; YONG KELVIN HIN-YEONG; ZOU NANFEI 权利人:CELGENE AVILOMICS RES INC 摘要:The present invention relates to methods for synthesizing compounds useful as inhibitors or both of ERK1 and ERK2 kinase, derivatives thereof, and intermediates thereto.
1: Aronchik I, Dai Y, Labenski M, Barnes C, Jones T, Qiao L, Beebe L, Malek M, Elis W, Shi T, Mavrommatis K, Bray GL, Filvaroff EH. Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance. Mol Cancer Res. 2018 Oct 1. doi: 10.1158/1541-7786.MCR-17-0554. [Epub ahead of print]
合成参考文献
参考文献:10.1021/acs.jmedchem.2c01244 摘要:Fu L, Chen S, He G, Chen Y, Liu B. Targeting Extracellular Signal-Regulated Protein Kinase 1/2 (ERK1/2) in Cancer: An Update on Pharmacological Small-Molecule Inhibitors. J Med Chem. 2022 Oct 27;65(20):13561–73. doi: 10.1021/acs.jmedchem.2c01244.